Expanded Indication Includes Adolescents, Ambulatory ECG, Continuous SpO2, and Non-Invasive Blood Pressure in the Home or Hospital Setting. CHICAGO, Feb. 7, 2024 /PRNewswire/ — Sibel Health, a leading digital health company, announced today that its continuous wearable monitoring…
Sibel Announces its 4th FDA Clearance for Continuous Wearable Vital Signs Monitoring with ANNE® One and Additional Strategic Collaboration with Ann & Robert H. Lurie Children’s Hospital of Chicago
This post was originally published on this site